Variants in the HMGCR locus were associated with breast cancer outcomes, but not with genome-wide variants for LDL-cholesterol, indicating there may be an off-target non-LDL-C-based mechanism regulated by HMGCR. This evidence concerns the gene HMGCR and breast cancer.